statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Bioventus price target raised by $3 at Craig-Hallum, here's why

Q4 2023 Bioventus Inc Earnings Call Transcript

Bioventus sees 2024 non-GAAP EPS 12c-20c, consensus 33c

Bioventus reports Q4 adjusted EPS 7c, consensus 2c

Bioventus Non-GAAP EPS of $0.07 beats by $0.05, revenue of $135.42M beats by $11.46M...

Bioventus Non-GAAP EPS of $0.07 beats by $0.05, revenue of $135.42M beats by $11.46M

Accelerated fourth quarter sales growth to 7.6%, organic growth* of 14.3%Appointed Rob Claypoole as President and Chief Executive Officer, bringing more than 20 years of leadership experience in the...

Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results

U.S. stocks were higher, with the Dow Jones index surging more than 200 points on Tuesday.
read more...

Bioventus Reports Upbeat Earnings, Joins Ranpak, Beachbody And Other Big Stocks Moving Higher On Tuesday

Bioventus trading halted, volatility trading pause

Robust Q4 Performance and Strategic Cost Management Propel Bioventus Inc (BVS) ForwardRelated Stocks: BVS...

Bioventus Inc (BVS) Reports Growth in Q4 Sales and Adjusted EBITDA, Provides Optimistic 2024 ...

El martes, 12 de marzo, Bioventus (NASDAQ:BVS) presentar las ganancias de su ltimo trimestre. Este es el resumen de Benzinga sobre la publicaci n de la compa a.
Ingresos netos, ganancias y...

Pron stico de ganancias para Bioventus

Bioventus, Inc. is a medical technology company, which focuses on developing and commercializing and proprietary orthobiologic products for the treatment of patients suffering from an array of musculoskeletal conditions. It operates through the following business segments: Active Healing Therapies-U.S, Active Healing Therapies-International, Surgical and BMP. The Active Healing Therapies-U.S and International offers two types of non-surgical products which are non-invasive exogen system for long bone stimulation for fracture healing and hyaluronic acid, or HA, viscosupplementation therapies for osteoarthritis pain relief. The Surgical segment offers a portfolio of advanced bone graft substitutes. The BMP segment comprises proprietary next-generation bone morphogenetic protein, or BMP. The company was founded on November 23, 2011 and is headquartered in Durham, NC.

Bioventus Inc - Ordinary Shares - Class A

Volume	53,010.00
52-Wk High	$6.08
52-Wk Low	$0.9499

Period	Estimated	Reported	Surprise	Result
Q1'24	-$0.07	--	--	N/A
Q4'23	$0.02	$0.07	265.61%	BEAT
Q3'23	-$0.02	$0.05	350.00%	BEAT
Q2'23	-$0.00	$0.14	4300.42%	BEAT
Q1'23	-$0.15	-$0.26	-73.33%	MISSED

BVS Bioventus Inc - Ordinary Shares - Class A

About

Feed

News

Sentiment

Earnings

Fundamentals